Living systematic review 1: Introduction - the Why, What, When and How.
about
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.Parenteral anticoagulation in ambulatory patients with cancer.Registration of systematic reviews in PROSPERO: 30,000 records and counting.Technology-assisted title and abstract screening for systematic reviews: a retrospective evaluation of the Abstrackr machine learning tool.Partially systematic thoughts on the history of systematic reviewsSystemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis
P2860
Living systematic review 1: Introduction - the Why, What, When and How.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Living systematic review 1: Introduction - the Why, What, When and How.
@en
type
label
Living systematic review 1: Introduction - the Why, What, When and How.
@en
prefLabel
Living systematic review 1: Introduction - the Why, What, When and How.
@en
P2093
P50
P1476
Living systematic review 1: Introduction - the Why, What, When and How.
@en
P2093
Harriet MacLehose
Ian Shemilt
James Thomas
Living systematic review Network
Mark Simmonds
Tari Turner
P356
10.1016/J.JCLINEPI.2017.08.010
P577
2017-09-01T00:00:00Z